etoposide has been researched along with 10-hydroxycamptothecin in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, SB; Gu, LQ; Huang, SL; Huang, ZH; Huang, ZS; Li, D; Ou, JB; Ou, TM; Shen, LL; Tan, JH; Wu, WB | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Andújar, I; Giner, RM; Recio, MC; Ríos, JL | 1 |
| Sun, H; Sun, Y; Wang, H; Xu, X; You, Q; Zhou, Y | 1 |
| Bi, CW; Chen, RX; Jiang, JD; Li, YB; Shao, RG; Song, DQ; Tang, S; Wang, YX; Zhang, CX; Zhao, WL | 1 |
| Chen, W; Hao, H; Lu, C; Shen, Y; Zhu, J | 1 |
| Gao, J; Jiang, F; Lu, Y; Wang, L; Wang, X; Wang, Z; Xi, T; Yan, Y | 1 |
| Andersson, BS; Ling, YH; Nelson, JA | 1 |
| Chen, LM; Ding, Y; Fu, LW; Liang, YJ; Pan, QC; Xiong, HY; Yang, XP | 1 |
1 review(s) available for etoposide and 10-hydroxycamptothecin
| Article | Year |
|---|---|
Lanostanoids from fungi: a group of potential anticancer compounds.
Topics: Antineoplastic Agents; Cell Cycle Checkpoints; Ganoderma; Lanosterol; Molecular Structure | 2012 |
8 other study(ies) available for etoposide and 10-hydroxycamptothecin
| Article | Year |
|---|---|
Synthesis and evaluation of mansonone F derivatives as topoisomerase inhibitors.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antigens, Neoplasm; Antineoplastic Agents; Carcinoma; Cell Line, Tumor; Cell Survival; DNA; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA-Binding Proteins; Drug Screening Assays, Antitumor; Etoposide; Humans; Inhibitory Concentration 50; Lung Neoplasms; Naphthoquinones; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Plasmids; Pyrans; Quinones; Sesquiterpenes; Structure-Activity Relationship; Telomerase; Topoisomerase Inhibitors | 2011 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Synthesis, cytotoxicity and topoisomerase II inhibitory activity of lomefloxacin derivatives.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Fluoroquinolones; HCT116 Cells; Humans; KB Cells; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2013 |
Discovery, synthesis and biological evaluation of cycloprotoberberine derivatives as potential antitumor agents.
Topics: Antineoplastic Agents; Berberine Alkaloids; Binding Sites; Cell Line, Tumor; Cell Survival; Crystallography, X-Ray; Cyclization; Drug Discovery; Drug Resistance, Neoplasm; Humans; Inhibitory Concentration 50; MCF-7 Cells; Models, Biological; Molecular Docking Simulation; Molecular Structure | 2013 |
Design and synthesis of 2-phenylnaphthalenoids and 2-phenylbenzofuranoids as DNA topoisomerase inhibitors and antitumor agents.
Topics: Antineoplastic Agents; Benzofurans; Catechols; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Topoisomerases; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Structure-Activity Relationship; Topoisomerase Inhibitors | 2015 |
Design, facile synthesis and biological evaluations of novel pyrano[3,2-a]phenazine hybrid molecules as antitumor agents.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Chemistry Techniques, Synthetic; Drug Design; Female; G2 Phase Cell Cycle Checkpoints; Humans; M Phase Cell Cycle Checkpoints; Mice; Phenazines; Xenograft Model Antitumor Assays | 2017 |
DNA topoisomerase I as a site of action for 10-hydroxycamptothecin in human promyelocytic leukemia cells.
Topics: Amsacrine; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Division; DNA Damage; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Drug Resistance; Enzyme Inhibitors; Etoposide; Humans; Leukemia, Promyelocytic, Acute; Mutation; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1990 |
[Experimental studies on treatment of nasopharyngeal carcinoma with combination regimen of hydroxycamptothecin and etoposide].
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cell Survival; Disease Models, Animal; Drug Resistance, Neoplasm; Etoposide; Mice; Mice, Inbred BALB C; Mice, Nude; Nasopharyngeal Neoplasms; Neoplasm Transplantation; Neoplasms, Experimental; Topoisomerase I Inhibitors; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2003 |